Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Strategies for infection control and prevalence of anti-SARS-CoV-2 IgG in 4,554 employees of a university hospital in Munich, Germany

View ORCID ProfileJohanna Erber, Verena Kappler, Bernhard Haller, Hrvoje Mijočević, Ana Galhoz, Clarissa Prazeres da Costa, Friedemann Gebhardt, Natalia Graf, Dieter Hoffmann, Markus Thaler, Elke Lorenz, Hedwig Roggendorf, Florian Kohlmayer, Andreas Henkel, Michael P Menden, Jürgen Ruland, View ORCID ProfileChristoph D Spinner, Ulrike Protzer, Percy Knolle, View ORCID ProfilePaul Lingor, on behalf of the SeCoMRI Study Group
doi: https://doi.org/10.1101/2020.10.04.20206136
Johanna Erber
1Technical University of Munich, School of Medicine, University Hospital rechts der Isar, Department of Internal Medicine II, Munich, Germany
2German Centre for Infection Research (DZIF), Munich Partner Site, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Johanna Erber
Verena Kappler
3Technical University of Munich, School of Medicine, Institute of Virology, Munich, Germany
4Technical University of Munich, School of Medicine, University Hospital rechts der Isar, Department for Sports Medicine, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bernhard Haller
5Technical University of Munich, School of Medicine, University Hospital rechts der Isar, Institute of Medical Informatics, Statistics and Epidemiology, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hrvoje Mijočević
3Technical University of Munich, School of Medicine, Institute of Virology, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ana Galhoz
6Institute of Computational Biology, Helmholtz Zentrum München-German Research Centre for Environmental Health, Neuherberg, Germany
7Department of Biology, Ludwig-Maximilians University Munich, Martinsried, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Clarissa Prazeres da Costa
8Technical University of Munich, School of Medicine, Institute for Medical Microbiology, Munich, Germany
9Technical University of Munich, School of Medicine, Centre for Global Health, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Friedemann Gebhardt
8Technical University of Munich, School of Medicine, Institute for Medical Microbiology, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Natalia Graf
3Technical University of Munich, School of Medicine, Institute of Virology, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dieter Hoffmann
2German Centre for Infection Research (DZIF), Munich Partner Site, Munich, Germany
3Technical University of Munich, School of Medicine, Institute of Virology, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Markus Thaler
10Technical University of Munich, School of Medicine, Institute of Clinical Chemistry and Pathobiochemistry, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elke Lorenz
4Technical University of Munich, School of Medicine, University Hospital rechts der Isar, Department for Sports Medicine, Munich, Germany
11Technical University of Munich, School of Medicine, Deutsches Herzzentrum Muenchen, Klinik für Herz- und Kreislauferkrankungen, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hedwig Roggendorf
12Technical University of Munich, School of Medicine, University Hospital rechts der Isar, Institute of Molecular Immunology, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Florian Kohlmayer
5Technical University of Munich, School of Medicine, University Hospital rechts der Isar, Institute of Medical Informatics, Statistics and Epidemiology, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andreas Henkel
13Technical University of Munich, School of Medicine, University Hospital rechts der Isar, Information Technology Department, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael P Menden
6Institute of Computational Biology, Helmholtz Zentrum München-German Research Centre for Environmental Health, Neuherberg, Germany
7Department of Biology, Ludwig-Maximilians University Munich, Martinsried, Germany
14German Centre for Diabetes Research (DZD e.V.), Neuherberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jürgen Ruland
2German Centre for Infection Research (DZIF), Munich Partner Site, Munich, Germany
10Technical University of Munich, School of Medicine, Institute of Clinical Chemistry and Pathobiochemistry, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christoph D Spinner
1Technical University of Munich, School of Medicine, University Hospital rechts der Isar, Department of Internal Medicine II, Munich, Germany
2German Centre for Infection Research (DZIF), Munich Partner Site, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Christoph D Spinner
Ulrike Protzer
2German Centre for Infection Research (DZIF), Munich Partner Site, Munich, Germany
3Technical University of Munich, School of Medicine, Institute of Virology, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: paul.lingor@tum.de protzer@tum.de
Percy Knolle
12Technical University of Munich, School of Medicine, University Hospital rechts der Isar, Institute of Molecular Immunology, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul Lingor
15Technical University of Munich, School of Medicine, University Hospital rechts der Isar, Department of Neurology, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Paul Lingor
  • For correspondence: paul.lingor@tum.de protzer@tum.de
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Hospital staff are at high risk of infection during the coronavirus disease (COVID-19) pandemic. We analysed the exposure characteristics, efficacy of protective measures, and transmission dynamics in this hospital-wide prospective seroprevalence study.

Methods and Findings Overall, 4554 individuals were tested for anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) IgG antibodies using a chemiluminescent immunoassay. Individual risk factors, use of personal protective equipment (PPE), occupational exposure, previous SARS-CoV-2 infection, and symptoms were assessed using a questionnaire and correlated to anti-SARS-CoV-2 IgG antibody titres and PCR testing results. Odds ratios with corresponding exact 95% confidence intervals were used to evaluate associations between individual factors and seropositivity. Spatio-temporal trajectories of SARS-CoV-2-infected patients and staff mobility within the hospital were visualised to identify local hotspots of virus transmission.

The overall seroprevalence of anti-SARS-CoV-2-IgG antibody was 2.4% [95% CI 1.9–2.9]. Patient-facing staff, including those working in COVID-19 areas, had a similar probability of being seropositive as non-patient-facing staff. Prior interaction with SARS-CoV-2-infected co-workers or private contacts and unprotected exposure to COVID-19 patients increased the probability of seropositivity. Loss of smell and taste had the highest positive predictive value for seropositivity. The rate of asymptomatic SARS-CoV-2 infections was 25.9%, and higher anti-SARS-CoV-2 IgG antibody titres were observed in symptomatic individuals. Spatio-temporal hotspots of SARS-CoV-2-positive staff and patients only showed partial overlap.

Conclusions Patient-facing work in a healthcare facility during the SARS-CoV-2 pandemic may be safe if adequate PPE and hygiene measures are applied. The high numbers of asymptomatic SARS-CoV-2 infections that escaped detection by symptomatic testing underline the value of cross-sectional seroprevalence studies. Unprotected contact is a major risk factor for infection and argues for the rigorous implementation of hygiene measures.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The study was funded by the Board of Directors of the University Hospital rechts der Isar, Munich.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was approved by the Ethics Committee of the Technical University of Munich, School of Medicine (approval number: 216/20S).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Anonymised aggregated data will be available to researchers upon reasonable request, which should be directed to the corresponding author. The source code of the trajectory analysis is available at https://github.com/AnaGalhoz37/SeCOMRI.

https://github.com/AnaGalhoz37/SeCOMRI

  • Abbreviations

    CI
    confidence interval
    CLIA
    chemiluminescent immunoassay
    ECLIA
    electrochemiluminescent immunoassay
    ELISA
    enzyme-linked immunosorbent assay
    HCW
    health care workers
    MRI
    University Hospital Munich rechts der Isar
    OR
    odds ratio
    PCR
    polymerase chain reaction
    PPE
    personal protective equipment
    SARS-CoV-2
    severe acute respiratory syndrome coronavirus 2
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
    Back to top
    PreviousNext
    Posted October 06, 2020.
    Download PDF

    Supplementary Material

    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Strategies for infection control and prevalence of anti-SARS-CoV-2 IgG in 4,554 employees of a university hospital in Munich, Germany
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Strategies for infection control and prevalence of anti-SARS-CoV-2 IgG in 4,554 employees of a university hospital in Munich, Germany
    Johanna Erber, Verena Kappler, Bernhard Haller, Hrvoje Mijočević, Ana Galhoz, Clarissa Prazeres da Costa, Friedemann Gebhardt, Natalia Graf, Dieter Hoffmann, Markus Thaler, Elke Lorenz, Hedwig Roggendorf, Florian Kohlmayer, Andreas Henkel, Michael P Menden, Jürgen Ruland, Christoph D Spinner, Ulrike Protzer, Percy Knolle, Paul Lingor, on behalf of the SeCoMRI Study Group
    medRxiv 2020.10.04.20206136; doi: https://doi.org/10.1101/2020.10.04.20206136
    Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
    Citation Tools
    Strategies for infection control and prevalence of anti-SARS-CoV-2 IgG in 4,554 employees of a university hospital in Munich, Germany
    Johanna Erber, Verena Kappler, Bernhard Haller, Hrvoje Mijočević, Ana Galhoz, Clarissa Prazeres da Costa, Friedemann Gebhardt, Natalia Graf, Dieter Hoffmann, Markus Thaler, Elke Lorenz, Hedwig Roggendorf, Florian Kohlmayer, Andreas Henkel, Michael P Menden, Jürgen Ruland, Christoph D Spinner, Ulrike Protzer, Percy Knolle, Paul Lingor, on behalf of the SeCoMRI Study Group
    medRxiv 2020.10.04.20206136; doi: https://doi.org/10.1101/2020.10.04.20206136

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Epidemiology
    Subject Areas
    All Articles
    • Addiction Medicine (216)
    • Allergy and Immunology (495)
    • Anesthesia (106)
    • Cardiovascular Medicine (1097)
    • Dentistry and Oral Medicine (196)
    • Dermatology (141)
    • Emergency Medicine (274)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (502)
    • Epidemiology (9773)
    • Forensic Medicine (5)
    • Gastroenterology (481)
    • Genetic and Genomic Medicine (2313)
    • Geriatric Medicine (223)
    • Health Economics (462)
    • Health Informatics (1562)
    • Health Policy (736)
    • Health Systems and Quality Improvement (604)
    • Hematology (238)
    • HIV/AIDS (504)
    • Infectious Diseases (except HIV/AIDS) (11650)
    • Intensive Care and Critical Care Medicine (617)
    • Medical Education (238)
    • Medical Ethics (67)
    • Nephrology (257)
    • Neurology (2144)
    • Nursing (134)
    • Nutrition (337)
    • Obstetrics and Gynecology (427)
    • Occupational and Environmental Health (518)
    • Oncology (1180)
    • Ophthalmology (364)
    • Orthopedics (128)
    • Otolaryngology (220)
    • Pain Medicine (147)
    • Palliative Medicine (50)
    • Pathology (311)
    • Pediatrics (695)
    • Pharmacology and Therapeutics (300)
    • Primary Care Research (267)
    • Psychiatry and Clinical Psychology (2182)
    • Public and Global Health (4663)
    • Radiology and Imaging (778)
    • Rehabilitation Medicine and Physical Therapy (457)
    • Respiratory Medicine (624)
    • Rheumatology (274)
    • Sexual and Reproductive Health (226)
    • Sports Medicine (210)
    • Surgery (252)
    • Toxicology (43)
    • Transplantation (120)
    • Urology (94)